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ABSTRACT
Fractions of an ultrafiltered Cyclopia genistoides extract, re-
spectively enriched in xanthones and benzophenones, were
previously shown to inhibit mammalian α-glucosidase in vitro.
The present study investigated ex vivo intestinal transport of
these fractions, using excised porcine jejunal tissue, to deter-
mine whether the gut could be a predominant in vivo site of
action. The major bioactive compounds, the xanthones (man-
giferin, isomangiferin) and benzophenones (3-β-D-glucopyra-
nosyliriflophenone, 3-β-D-glucopyranosyl-4-O-β-D-glucopyr-
anosyliriflophenone) exhibited poor permeation in the ab-
sorptive direction with a relatively high efflux ratio (efflux ra-
tio > 1). The efflux ratio of 3-β-D-glucopyranosyl-4-O-β-D-glu-
copyranosyliriflophenone (3.05) was similar to rhodamine
123 (2.99), a known substrate of intestinal P-glycoprotein 1
efflux transporters. Low epithelial membrane transport rates,
coupled with efflux mechanisms, would effectively concen-
trate these bioactive compounds at the target site (gut lu-
men). Storage stability testing and moisture sorption assays
of the xanthone-enriched fraction, benzophenone-enriched
fraction, and ultrafiltered Cyclopia genistoides extract were
performed to determine their susceptibility to physical and
chemical degradation during storage. Hygroscopicity of the
powders, indicated by moisture uptake, decreased in the or-
der: benzophenone-enriched fraction (22.7%) > ultrafiltered
Cyclopia genistoides extract (14.0%) > xanthone-enriched frac-
tion (10.7%). 3-β-D-Glucopyranosylmaclurin, a minor benzo-
phenone, was the least stable of the compounds, degrading
faster in the benzophenone-enriched fraction than in ultrafil-
tered Cyclopia genistoides extract, suggesting that the ultrafil-
tered extract matrix may provide a degree of protection
against chemical degradation. Compound degradation during
12 wk of storage at 40 °C in moisture-impermeable containers
was best explained by first order reaction kinetics.
Physicochemical Stability of Enriched Phenolic Fractions
of Cyclopia genistoides and ex vivo Bi-directional Permeability
of Major Xanthones and Benzophenones
Original Papers













































PABapp apparent permeability coefficient in the
absorptive direction
PBAapp apparent permeability coefficient in the
secretory direction
TEER trans-epithelial electrical resistance

































Various phytochemicals have gained attention because of remark-
able in vitro bioactivity, but many promising lead compounds may
be unsuitable candidates for nutraceutical development because
of low systemic bioavailability (i.e., failure to reach and maintain
therapeutic plasma concentrations) [1]. However, low bioavaila-
bility of bioactive compounds is of less concern when the thera-
peutic target is located in the GIT itself, as opposed to compounds
that require systemic bioavailability through intestinal absorption
to achieve therapeutic plasma concentrations [2].
The close interrelationship between diet and metabolic disor-
ders such as obesity and type 2 diabetes mellitus has created op-
portunities for the development of antidiabetic functional food in-
gredients or nutraceuticals as adjuncts to first-line treatments
such as lifestyle modification and pharmacotherapy [3]. In this
context, the search for natural AGIs, which inhibit the enzymatic
digestion of dietary carbohydrates in the small intestine, thereby
preventing postprandial hyperglyaemia, is warranted. Promising
natural AGIs represent large chemical diversity and include poly-
phenols [4].
Previously, we confirmed in vitro AGI activity for several of the
major phenolic compounds in the herbal tea, Cyclopia genistoides
(L.) Vent. (Family: Fabaceae; Tribe: Podalyrieae) (▶ Fig. 1) (i.e.,
mangiferin, isomangiferin, I3G, and IDG), as well as for the minor
benzophenone, M3G, [5,6] as part of an ongoing development of
an antidiabetic nutraceutical extract and/or XEF and BEF, respec-
tively [6, 7]. Studies in the pig [8], rat [9], and human [10] con-
firmed that mangiferin is poorly bioavailable. Ex vivo transport
studies, using porcine small intestine, also showed low bioavaila-
bility for mangiferin as well as for isomangiferin [11,12], I3G, and
IDG [12]. A methanolic extract of C. subternata Vogel and a hydro-
ethanolic extract of C. genistoides were used in the respective
studies. In the present study, we revisited the intestinal perme-
ability of the major xanthones and benzophenones of C. genis-
toides, since extract composition could affect transport of com-
pounds across the intestinal membrane. Tian et al. [13] demon-
strated that in vivo intestinal absorption of mangiferin in rats was326 Miller N et al. Physicochigher when present in a Rhizoma Anemarrhenae extract com-
pared to purified mangiferin.
Another important consideration in the development of a
functional food or nutraceutical ingredient is the shelf-life of inter-
mediate products, as poor stability would affect the efficacy. Sta-
bility tests are employed to gain an understanding of chemical
stability of compounds during bulk storage. A study on a spray-
dried C. subternata hot water extract demonstrated that the deg-
radation of mangiferin, isomangiferin, and IMG, among others,
followed a pseudo-first order reaction model and that the compo-
sition of the product affected the degradation rate constants [14].
Compositional differences between the ultrafiltered C. genistoides
extract and semi-purified fractions are therefore expected to af-
fect their chemical stability.
The present study aimed to evaluate the intestinal epithelial
membrane permeability of the major compounds of C. genistoides
when present in the semi-purified fractions, XEF and BEF. A bi-
directional intestinal permeability assay was used for determining
efflux characteristics ex vivo [15]. Additionally, we aimed to delin-
eate the reaction kinetic behavior of the target compounds during
accelerated storage of the extract and fractions to gain insight
into their relative shelf-life stability.Results and Discussion
Low systemic bioavailability of dietary polyphenols underpins
their potential as intestinal enzyme inhibitors, as their confine-
ment to the GIT lumen due to weak membrane permeability
places them at the intended site of action [16]. Intestinal mem-
brane permeability and aqueous solubility of compounds form
the basis of the Biopharmaceutics Classification System, which al-
lows broad predictions of the rate-limiting step in their intestinal
absorption following oral administration [17]. Transport across
excised porcine intestinal tissue was used to assess the potential
of xanthones and benzophenones of C. genistoides (▶ Fig. 1) to
target α-glucosidase in the lumen of the GIT.
Bidirectional intestinal epithelial permeability assays were con-
ducted to determine the permeability of each target compound
both as a constituent of its parent fraction (XEF0 or BEF0) or as a
constituent of its parent fraction tested in combination with the
other fraction. The mangiferin and isomangiferin content of XEF0
were 37.1 and 11.1%, respectively, whereas the IDG, I3G, and
M3G content of BEF0 were 7.0, 5.2, and 4.1%, respectively.
Use of the Sweetana-Grass diffusion apparatus required
mounting of freshly excised porcine intestinal tissue sections
(< 20min post-slaughter). Tissue integrity was maintained as indi-
cated by low transport of Lucifer yellow (< 5%) [18] and a TEER val-
ue > 30Ω · cm2, considered acceptable for excised small intestinal
tissue [19] over the experimental period (Table 1S, Supporting In-
formation).
The apparent permeability coefficient (Papp), defined as the ini-
tial flux of a compound across a membrane, normalized by the
membrane surface area and donor compartment concentration,
is commonly used for general screening purposes in in vitro or ex
vivo intestinal permeability studies [20]. The ER, representing the
ratio of the Papp value for the secretory (B‑A) direction vs. the ab-
sorptive (A–B) direction, is indicative of the degree of efflux of ahemical Stability of… Planta Med 2021; 87: 325–335 | © 2020. Thieme. All rights reserved.
▶ Table 1 Apparent permeability coefficients and efflux ratios for the 2 major xanthones, mangiferin and isomangiferin, and the 2 major benzo-
phenones, IDG and I3G, in Cyclopia genistoides fractions, tested individually or in combination, for ex vivo intestinal permeability.
Compound Single fractions (XEF0 or BEF0 individually) Combined fractions (1XEF0 :1BEF0)
PABapp (× 10
−7 cm/s) PBAapp (× 10
−7 cm/s) Efflux ratio PABapp (× 10
−7 cm/s) PBAapp (× 10
−7 cm/s) Efflux ratio
IDG 1.29 ± 0.1 3.93 ± 0.1 3.05 0.96 ± 0.3 2.05 ± 1.3 2.14
I3G nd 10.1 ± 1.6 – – traces –
Mangiferin 0.93 ± 0.3 1.60 ± 0.1 1.71 1.43 ± 0.1 2.41 ± 0.5 1.68
Isomangiferin 1.06 ± 0.4 1.91 ± 0.1 1.81 1.78 ± 0.2 2.73 ± 0.7 1.53
Rhodamine 123 1.38 ± 0.4 4.12 ± 1.8 2.99 – – –
AB, apical-to-basolateral direction (absorption); BA, basolateral-to-apical direction (efflux); BEF, benzophenone-enriched fraction; IDG, 3-β-D-glucopyra-
nosyl-4-O-β-D-glucopyranosyliriflophenone; I3G, 3-β-D-glucopyranosyliriflophenone; nd, not detected;, apparent permeability coefficient; XEF, xanthone-
enriched fraction. Papp values are presented as mean ± standard deviation (n = 3).
▶ Fig. 1 Structures of major xanthones and benzophenones found in honeybush (Cyclopia genistoides Vent.). I3G, 3-β-D-glucopyranosyliriflophe-

































l.given compound (i.e., ER = 1 indicates that no efflux occurred, ER
> 2 suggests active efflux mechanisms are involved, and 1 < ER < 2
suggests that passive permeation mechanisms dominate [21].
For transport in the absorptive (A–B) direction, I3G was not de-
tected in the acceptor compartment over the experimental peri-
od, precluding calculation of PABapp and ER values for this compound
when tested as a constituent of BEF0 (▶ Table 1). Calculation of
Papp was also not possible for I3G when present in the combined
fractions because of low transport rates across the membrane in
either direction. Although this cannot provide further insight into
the extent of efflux of I3G, it does indicate that I3G is unlikely to be
absorbed to a great degree by enterocytes into the blood circula-
tion. ER values for mangiferin and isomangiferin were between 1
and 2 (1.53–1.81), whereas for IDG ER = 3.05 was similar to that of
Rhodamine 123 (ER = 2.99), a known substrate for the intestinal
glycoprotein efflux transporter, P-glycoprotein 1 (P‑gp) [22]. Var-
ious dietary flavonoids induce the P‑gp expression by enterocytes
in vitro and in vivo, an adaptation thought to serve as a defenseMiller N et al. Physicochemical Stability of… Planta Med 2021; 87: 325–335 | © 2020. Thieme.mechanism against the entry of lipophilic xenobiotics into the or-
ganism [23]. Mangiferin has been confirmed as a P‑gp substrate in
a Caco-2 cell study [24]; mangiferin, isomangiferin, IDG, and I3G,
as constituents of C. genistoides extract, upregulated the P‑gp ef-
flux drug transporter encoded by the ABCB1 gene in C3A liver
cells, treated at concentrations up to 250 µg/mL (i.e., 0.4–
0.6mM) [25]. However, such cell models cannot mimic additional
factors (e.g., mucus layer secretions and tight junctions) that
come into play in vivo [26]. The ex vivo assay system employed in
the present study more closely mirrors physiological conditions.
Further context in terms of the present results and previous
cell-based studies is the confirmed low oral bioavailability and tis-
sue disposition of many dietary polyphenols (i.e., their tendency
to not reach target tissues at the required concentrations follow-
ing interaction with microbiota, absorption, and phase II metabo-
lism) [27]. For example, oral bioavailability of mangiferin in nor-
mal and alloxan-induced diabetic rats amounted to just 1.71%


































l.tions reached after oral administration of 400mg/kg mangiferin
to normal and streptozotocin-induced diabetic rats were
715.04 ± 600.14 ng/mL and 1995.52 ± 408.97 ng/mL, respective-
ly [29]. Although in vivo studies are ideal, evidence of in vitromod-
ulation of P‑gp in cell-based models is useful, as it emphasizes the
likelihood of in vivo efflux of dietary polyphenols by cells express-
ing the P‑gp transporter in high amounts, such as small intestinal
enterocytes [23].
Additional to the dominance of efflux mechanisms in the trans-
port of the target compounds, an examination of their structural
features may also provide insight. Not only is the violation of 2 or
more of Lipinskiʼs “rule of 5” criteria predicted to lead to poor oral
bioavailability of a compound [30], as indicated for the target
compounds (Table 2S, Supporting Information), but Seelig [31]
noted that binding to P‑gp increases with the strength and num-
ber of electron donor or hydrogen bond acceptor groups. The
higher ER of IDG compared with those of the xanthones could be
related to its additional glucose moiety, resulting in a molar mass
> 500 g/mol, larger polar surface area, and greater number of hy-
drogen bond acceptor groups and “rule of 5” violations (3), sug-
gesting its stronger affinity to P‑gp. I3G with lower membrane
permeability than the xanthones (▶ Table 1) has the same num-
ber of hydrogen bond donors than the 2 xanthones (i.e., 8), but
1 less hydrogen bond acceptor (10 vs. 11) and 2 more rotatable
bonds (4 vs. 2).
Although the “rule of 5” can give an indication of oral bioavail-
ability based on molecular features, it does not account for other
factors (e.g., the presence of other constituents in a multi-com-
pound extract or the in vivo gastrointestinal environment). More-
over, some authors have diverged in their interpretation of the
“rule of 5”, (e.g., 2 widely cited review articles have claimed that
the molecular structure of mangiferin fulfills the Lipinski criteria
that predict good oral bioavailability [32,33], despite overwhelm-
ing evidence to the contrary reported elsewhere) [8–12,28,29].
Data such as those reported in the present study add to the body
of evidence that confirms low oral bioavailability, related to P‑gp
and/or passive efflux mechanisms, and supports the notion of fo-
cusing on an intestinal target.
Evidence from other studies, one using Caco-2 cells [34] and
another in rats [13], indicated that mangiferin showed higher in-
testinal permeability as part of a plant extract than as a pure stan-
dard, suggesting that its absorption could be enhanced by other
extract constituents. Mortimer [11], measuring the transport of
mangiferin, isomangiferin, and I3G present in a methanolic ex-
tract of C. subternata (1.9, 0.6, and 0.7%, respectively) across por-
cine intestine using a flow-through diffusion system, showed con-
centration-dependent diffusion of the compounds across the
small intestine. I3G had a slightly higher PABapp value than mangifer-
in and isomangiferin, different from the results of the present
study. Previously, Raaths [12] showed ER values > 1 across porcine
small intestinal section, not only for IDG, mangiferin, and isoman-
giferin but also for I3G. The compounds were present in a crude,
nonultrafiltered extract of C. genistoides and its fractions. The ex-
tract from which XEF0 and BEF0 were prepared for the present
study was ultrafiltered through a 10 kDa regenerated cellulose
membrane, which removed large molecules and changed extract
composition [35]. The modulatory effects of dietary amino acids,328 Miller N et al. Physicocpolyphenols, and various natural extracts on intestinal tight junc-
tions have been described elsewhere [36,37]. Glucose and sodi-
um, when present as food additives, are also known to enhance
intestinal permeability [38]. As the extracts and fractions of
C. genistoides are not fully characterized at this stage, such modu-
latory effects on absorption, due to matrix effects, cannot be
ruled out.
The results of our study confirmed the validity of developing an
antidiabetic nutraceutical containing C. genistoides xanthones and
benzophenones, aimed at the inhibition of intestinal AG. Low
transport rates across the epithelial membrane, coupled with
efflux mechanisms (likely mediated by P‑gp transporters), would
effectively concentrate the compounds at the intended site of
action (GIT lumen).
The moisture sorption characteristics of dried plant extracts,
intended for commercialization as functional products or ingre-
dients, is important when selecting suitable packaging material
and specifying storage and handling conditions. Uptake of mois-
ture by hygroscopic products would accelerate physical and
chemical changes as shown for a spray-dried Cyclopia subternata
extract that deliquesces at > 25 °C and > 55% RH) [14]. In the
present study, M3G was the most labile of the compounds inves-
tigated and showed greater stability in UCGE0 than in BEF0 (▶ Ta-
ble 2), indicating that composition of the ultrafiltered extract
(prefractionation) may provide a degree of protection against
chemical degradation. The rate of moisture uptake was rapid dur-
ing the first 18 h of storage (BEF0 > UCGE0 > XEF0; ▶ Fig. 2), there-
after approaching steady state. After 96 h, the mass increases of
BEF0, UCGE0, and XEF0 were 22.7, 14.0, and 10.7%, respectively,
with visible liquefaction of UCGE0 and BEF0 while XEF0 retained
the superficial appearance of a dry product (Fig. 2S, Supporting
Information).
Moisture sorption analysis of freeze-dried samples at 25 °C
confirmed that BEF0 was substantially more hygroscopic than
XEF0, with mass increases of 72.5% and 21.3%, respectively, mea-
sured at 97% RH (▶ Fig. 3). Also included in the moisture sorption
analysis was D-pinitol, which is present in substantial quantities in
UCGE0 (6.1%) and BEF0 (8.2%), compared to XEF0 (0.3%) (Page 6,
Supporting Information). It showed a sharp increase in mass
(90.9%) due to moisture uptake at RH > 75%, a clear indication
that its presence in these samples contributed to their moisture
uptake. BEF0 was produced by desorbing a UCGE0-loaded resin
column with dilute aqueous solutions of ethanol (5–10% v/v).
Therefore, it could be expected that the majority of hydrophilic
constituents in UCGE0 would have desorbed along with the target
benzophenones in BEF0. In addition to D-pinitol, BEF0 contained
1.6% D-glucose, which was not detected in XEF0. The greater de-
gree of moisture uptake in BEF0 could also be related to the addi-
tional glucosyl moiety of IDG, its major benzophenone (7.04% w/
w), which was not present in XEF0. UCGE0 and XEF0 can be classi-
fied as “hygroscopic” and BEF0 as “very hygroscopic” [39].
According to International Conference on Harmonisation (ICH)
guidelines, a decrease in the concentration of bioactive com-
pound > 5% during accelerated stability testing is considered a
“significant change” [40]. Given the rapid increase in moisture
content of UCGE0, XEF0, and BEF0, accompanied by target com-
pound degradation at 40 °C/75% RH (▶ Fig. 2), further investiga-hemical Stability of… Planta Med 2021; 87: 325–335 | © 2020. Thieme. All rights reserved.
▶ Table 2 Change in target compound content of ultrafiltered Cyclopia genistoides extract and its xanthone- and benzophenone-enriched fractions
after 96 h of storage with mini-hygrostat (40 °C/75% RH).
Compound UCGE0a XEF0b BEF0c
Initiald 96 he Δ (%)f Initial 96 h Δ (%) Initial 96 h Δ (%)
MGFg 11.80 ± 0.08 11.51 ± 0.34 − 2.8 37.05 ± 0.24 36.86 ± 0.30 − 0.5 – – –
IMGFh 3.36 ± 0.02 3.32 ± 0.10 − 1.1 11.06 ± 0.07 10.55 ± 0.18 − 4.5 – – –
IDGi 1.18 ± 0.01 1.12 ± 0.03 − 4.8 – – – 7.04 ± 0.02 6.99 ± 0.09 − 0.7
M3Gj 0.55 ± 0.01 0.50 ± 0.01 − 9.5 – – – 4.07 ± 0.07 3.44 ± 0.13 − 15.4
I3Gk 1.48 ± 0.00 1.35 ± 0.03 − 8.8 3.33 ± 0.03 3.11 ± 0.02 − 6.5 5.22 ± 0.13 4.7 4 ± 0.05 − 9.2
a ultrafiltered Cyclopia genistoides extract; b xanthone-enriched fraction; c benzophenone-enriched fraction; d initial content (g/100 g d.b.) and e content
(g/100 g d. b.after 96 hours; f percentage change in content after 96 h; g mangiferin; h isomangiferin; i 3-β-D-glucopyranosyl-4-O-β-D-glucopyranosyliriflo-


































l.tion of their chemical stability was merited in the absence of high
RH by placing the samples in moisture-impermeable containers.
For countries with a subtropic/Mediterranean climate such as
South Africa, the ICH recommends 40 °C/75% RH for accelerated
(6 months) storage testing [41]. An abbreviated storage period of
12 wk was employed, and the moisture-impermeable container
mimicked the type of packaging proposed for storage and distri-
bution. Sample mass did not increase during storage, confirming
that compound degradation would be the result of temperature
and not due to moisture uptake.
The first order reaction model was selected to model com-
pound degradation (▶ Table 3) and to fit the data for calculation
of degradation rate constants (k) (▶ Fig. 4) in accordance with
other studies on the thermal degradation kinetics of the xan-
thones and benzophenones of C. genistoides [42,43]. The rela-
tively low percentage of xanthone degradation (13.35–15.59%)
resulted in a weaker fit of the data to the various models
(0.531 < R2adj < 0.791) compared with the benzophenones
(0.633 < R2adj < 0.894). M3G was again most susceptible to degra-
dation over the 12-wk storage period, while IDG was the most sta-
ble compound (degradation < 13%) and subsequently not fitted
to the kinetic models. The first order degradation rate constants
(k) and percentage degradation at 6 wk and 12 wk of storage are
presented in ▶ Table 4. The highest k-values were observed for
the most heat-labile compound, M3G, which degraded at a higher
rate in BEF0 (k = 0.0503) than UCGE0 (k = 0.0347). The relative
chemical stability of the compounds was similar to that observed
in an aqueous model solution (pH 5) (i.e., M3G < mangiferin < I3G
< isomangiferin < IDG) [42] and in C. genistoides plant material
during high-temperature oxidation, an essential step in the prod-
uction of “fermented” honeybush tea [43].
In conclusion, poor intestinal membrane permeation of the
major bioactive xanthones and benzophenones of C. genistoides
confirmed their suitability for further investigation as potential in-
testinal α-glucosidase inhibitors. The hygroscopicity of the dried
C. genistoides extract and fractions, particularly BEF0, and the sus-
ceptibility of some of the target compounds to degrade at 40 °C
accelerated by humid environmental conditions (75% RH) empha-
size the need to provide adequate barrier packaging to protectMiller N et al. Physicochemical Stability of… Planta Med 2021; 87: 325–335 | © 2020. Thieme.the active compounds. These findings serve as proof of concept
toward the development of an efficacious antidiabetic nutraceut-
ical product derived from C. genistoides.Materials and Methods
Chemicals and reagents
Rhodamine 123, Krebs-Ringer bicarbonate (KRB) buffer, and
DMSO were purchased from Sigma-Aldrich. Authentic phenolic
standards (purity > 95%) were obtained from Sigma-Aldrich (man-
giferin; D-pinitol), Phytolab (I3G; isomangiferin), or isolated (IDG
and M3G) from C. genistoides [5]. All other reagents were of ana-
lytical grade and supplied by Sigma-Aldrich or Merck.
Extract and fractions
Ultrafiltered Cyclopia genistoides extract (UCGE0) (retention sam-
ple code: ARC 2038P) and triplicate XEFs and BEFs (A to C) were
produced as described [7]. XEF0 was obtained by combining an
equal mass of XEF A, B, and C, while BEF0 was obtained by combin-
ing an equal mass BEF A, B, and C (retention samples coded as
ARC2038-XEF A, etc.).
Ex vivo intestinal permeability
Viable porcine jejenum tissue, obtained from the abattoir, was
prepared for intestinal permeability assays along with KRB buffer,
adjusted to pH 7.4 using 2M NaOH, as previously described [22].
The 2 fractions (XEF0, BEF0) and a 1 :1 XEF0:BEF0 combination
were dissolved in KRB buffer (1.71mg/mL) and the temperature
equilibrated at 37 °C prior to the transport experiment.
Intestinal tissue sections were mounted on the half-cells of a
Sweetana-Grass diffusion apparatus (Fig. 1S, Supporting Informa-
tion), with the mucosal side facing the apical chamber (transport
surface area = 1.78 cm2). The half-cells were clamped together to
form diffusion chambers that were inserted in the apparatus,
maintained at 37 °C. KRB buffer (7mL) at 37 °C was added to each
half-cell compartment, followed by continuous bubbling of a
carbogen gas mixture (95% O2:5% CO2) through the buffer in


















































































































































































Storage period at 40°C/75% RH (h)
Storage period at 40°C/75% RH (h)
































▶ Fig. 2 Remaining content of the target compounds (%) and degree of moisture uptake (expressed as % mass increase) in freeze-dried (a) ultra-
filtered Cyclopia genistoides extract (UCGE0), (b) xanthone-enriched fraction (XEF0), and (c) benzophenone-enriched fraction (BEF0) as a function of
time during storage at 40 °C/75% RH for 96 h in sealed glass vials containing saturated NaCl mini-hygrostats. (I3G = 3-β-D-glucopyranosyliriflophe-
none; IDG = 3-β-D-glucopyranosyl-4-O-β-D-glucopyranosyliriflophenone; M3G = 3-β-D-glucopyranosylmaclurin). Values are presented as mean ±


































l.the tissue to the experimental conditions whereafter the contents
of all compartments were aspirated to remove the buffer. Trans-
port in the absorptive (apical-to-basolateral, A–B) direction was
investigated by adding 7mL KRB buffer (37 °C) to the basolateral330 Miller N et al. Physicoc(serosal) compartment, and an equal volume of the test solution
to the apical (mucosal) compartment at 0min. Transport in the
secretory direction (basolateral-to-apical, B‑A) was investigated
by adding 7mL KRB buffer (37 °C) to the apical compartment,hemical Stability of… Planta Med 2021; 87: 325–335 | © 2020. Thieme. All rights reserved.
Relative humidity (%)


























▶ Fig. 3 Increase in mass of freeze-dried ultrafiltered Cyclopia gen-
istoides extract (UCGE0), xanthone-enriched fraction (XEF0), benzo-
phenone-enriched fraction (BEF0), and D-pinitol due to moisture




























l.and an equal volume of the test solution to the basolateral com-
partment at 0min. The tissue was exposed to the test solution for
2 h, during which samples (500 µL) were collected from the ac-
ceptor compartment at 20-min intervals and replaced with an
equal volume of KRB buffer (37 °C) [22]. All samples were freeze-
dried and stored at − 18°C until quantification of the target com-
pounds by HPLC‑DAD. All the transport studies were carried out in
triplicate.
The apparent permeability coefficient (cm/s) (Papp) for each












where dQ/dt is the permeability rate (slope of % transport/min
curve), A is the transport surface area (cm2), and C0 is the initial
compound concentration on the donor side.▶ Table 3 Adjusted coefficient of determination (R2adj) between mean obse
compounds in UCGE0, XEF0, and BEF0.
Compound Stored sample Adjusted coefficient of de
Zero ordera F
Mangiferin UCGE0e 0.676 0
XEF0f 0.531 0
Isomangiferin UCGE0 0.722 0
XEF0 0.749 0
I3Gg UCGE0 0.824 0
BEF0h 0.633 0
M3Gi UCGE0 0.816 0
BEF0 0.818 0
a zero order model: C = C0 – kT; b first order model: C = C0−kT; c second order mod
where C0 is the initial content (g/100 g sample, d. b.), T is the time in wk, k is the
(g/100 g sample, d.b.); e ultrafiltered Cyclopia genistoides extract used as startin
glucopyranosyliriflophenone; h benzophenone-enriched fraction; i 3-β-D-gluco
Miller N et al. Physicochemical Stability of… Planta Med 2021; 87: 325–335 | © 2020. Thieme.
de
d
The ER is an index of intestinal permeability that compares the







where PBAapp and P
AB
app represent Papp values in the basolateral-to-api-
cal (B‑A) and apical-to-basolateral (A–B) directions, respectively.
Rhodamine 123, a fluorescence marker and substrate of the
P‑gp efflux transporter [22], served as the model compound for
the bidirectional transport studies. It was dissolved in KRB buffer
to a final concentration of 5mM. The samples collected during the
bidirectional transport study (in triplicate in both the A–B and B‑A
directions) were analyzed for rhodamine 123 content using a
validated fluorescence spectroscopy assay (λEx = 480 nm; λEm =
520 nm) [22] and a Spectramax Paradigm® multi-mode detection
platform plate reader (Molecular Devices, LLC).
Lucifer yellow was included as an exclusion marker to indicate
excised tissue integrity over the experimental time period [18].
The lucifer yellow transport study was carried out only in the A–B
direction and the lucifer yellow concentration in the samples
quantified by fluorescence spectroscopy assay (λEx = 485 nm;
λEm = 535 nm) [45]. The TEER was measured using an ECA 825A
Dual Channel Epithelial Voltage Clamp (Warner Instruments) at
the start of the experiment with addition of the sample and at
the end of the 2 h sampling period.
Storage stability
Stability testing of target compounds in XEF0 and BEF0, as well as
the original extract (UCGE0), was performed in triplicate under ac-
celerated storage conditions (40 °C/75% relative humidity, RH)
over a period of 96 h. Mini-hygrostats, containing a saturated NaCl
solution and constructed as described by Human et al. [46], were
loaded with ca. 30mg freeze-dried sample (accurately weighed to
5-decimals), sealed, placed in a darkened stability cabinet at 40 °Crved content and predicted contents for the major Cyclopia genistoides
termination (R2adj)









el: C = C0/(1 + kTC0); d fractional conversional model: C = C∞ + (C0 – C∞)−kT,
reaction rate constant (wk−1), and C∞ is the stable fraction of the compound







▶ Table 4 Degradation (%) and first ordera degradation rate constants (k) for Cyclopia genistoides xanthones in powdered samples stored at 40 °C in














UCGE0b 8.11 ± 0.9* 15.59 ± 1.3 0.0125 ± 0.0017 7.15 ± 0.1* 13.35 ± 1.0 0.0153 ± 0.0019














UCGE0 21.86 ± 5.7 28.81 ± 8.4 0.0326 ± 0.0029 20.19 ± 5.7 32.43 ± 10.5 0.0347 ± 0.0033
BEF0d 29.72 ± 4.7 37.39 ± 8.9 0.0318 ± 0.0044 31.79 ± 3.9 46.28 ± 6.1 0.0503 ± 0.0042
a first order model: C = C0−kTwhere C0 is the initial content (g/100 g sample, d. b.), T is the time in wk, and k is the reaction rate constant (wk−1); b ultrafiltered
Cyclopia genistoides extract; c xanthone-enriched fraction; d benzophenone-enriched fraction. Percentage decrease values are given as mean ± standard
































































































































































▶ Fig. 4 First order model predicted values (indicated by [F], solid and broken lines) and experimental data (markers only) for degradation of (a)
mangiferin, (b) isomangiferin, (c) 3-β-D-glucopyranosyliriflophenone (I3G), and (d) 3-β-D-glucopyranosylmaclurin (M3G) in different freeze-dried
samples (UCGE0, ultrafiltered Cyclopia genistoides extract; XEF0, xanthone-enriched fraction; BEF0, benzophenone-enriched fraction) as a function
of time during storage at 40 °C/75% relative humidity for 12 wk in moisture-impermeable amber glass vials. Values are presented as mean ± stan-
dard deviation (n = 3, except * n = 2, outlier removed).



































































l.(SMC Scientific Manufacturing), and removed from storage after
6, 12, 18, 24, 36, 48, 72, and 96 h. The increase in the sample
mass due to moisture uptake was determined gravimetrically.
After reweighing, 15mL aqueous (DMSO) (10%, v/v) was added
to each vial to obtain a solution with a concentration of ca. 2mg/
mL. Aliquots were stored at − 18 °C until HPLC‑DAD analysis.
Stability of the target compounds in UCGE0, XEF0, and BEF0
was also investigated during a 12-wk storage period under “dry”
conditions at 40 °C. Approximately 50mg of freeze-dried sample
was weighed into 24mL amber glass vials, sealed with PTFE
screw-caps to mimic moisture-impermeable packaging, and
placed in a darkened stability cabinet at 40 °C. Samples were re-
moved from the cabinet after 1, 2, 3, 4, 6, 8, 10, and 12 wk of stor-
age. The content of each vial was dissolved in 15mL aqueous
DMSO (10%, v/v), equaling a concentration of ca. 3.3mg/mL. Ali-
quots were stored at − 18 °C until HPLC‑DAD analysis.
Moisture sorption analysis
Moisture sorption analysis was performed on UCGE0, XEF0, and
BEF0 by exposing the freeze-dried samples to 8 different saturated
salt solutions, resulting in a step-wise increase in the % RH over
consecutive days [47]. Saturated salt solutions were prepared by
dissolving a known amount of salt (g) (Table 3S, Supporting Infor-
mation) in a known volume of deionized water at room tempera-
ture (25 °C). Predetermined amounts (ca. 50–100mg) of each
sample were weighed and dried at 40 °C for 1 h in a laboratory
oven (Labotec) and weighed using a 5-decimal digital balance
(Mettler-Toledo International Inc.) to determine the initial dry
mass. The samples were placed in a desiccator containing the sat-
urated salt solution, and the mass of each sample was determined
after 24 h of exposure to the atmosphere with known RH. Sample
mass was determined until 48 h elapsed, or until equilibrium in
the mass was achieved. The experiment was continued by replac-
ing the first salt solution with the subsequent salt solutions in the
order shown in Table 3S (Supporting Information). The same
equilibration protocol was followed in each instance. For each
sample, the percentage mass increase was plotted against the in-
crease in RH.
HPLC with diode array detection (HPLC‑DAD)
Quantification of the major phenolic compounds in all samples
were performed by HPLC‑DAD using a validated method devel-
oped specifically for C. genistoides [48]. The instrument consisted
of an Agilent 1200 series system with an in-line degasser, auto-
sampler, column thermostat, quaternary pump, and diode array
detector (Agilent Technologies Inc.). Separation was achieved on
a Kinetex column (150 × 4.6mm ID, 2.6 µm dp; Phenomenex)
maintained at 30 °C, with the mobile phase consisting of (A) 1%
aqueous formic acid (v/v), (B) methanol, and (C) acetonitrile at a
flow rate of 1.0mL/min. Multi-linear gradient elution was carried
out as follows: 0min (95.0% A, 2.5% B, 2.5% C), 5min (95.0% A,
2.5% B, 2.5% C), 45min (75% A, 12.5% B, 12.5% C), 55min (50%
A, 25.0% B, 25.0% C), 56min (50% A, 25.0% B, 25.0% C), 57min
(95.0% A, 2.5% B, 2.5% C), 65min (95.0% A, 2.5% B, 2.5% C).
UV‑Vis spectra were recorded at 200–700 nm, with selective
wavelength monitoring at 288 nm (benzophenones) and 320 nm
(xanthones). The quantification of the compounds was based onMiller N et al. Physicochemical Stability of… Planta Med 2021; 87: 325–335 | © 2020. Thieme.6-point calibration curves, spanning expected concentration
ranges. IDG and isomangiferin were quantified using response
factors vs. I3G and mangiferin, respectively. Ascorbic acid was
added to samples prior to analysis to prevent oxidation of com-
pounds. After mixing, the samples and standard mixtures were fil-
tered using 0.45 µm Millex-HV syringe filters (Merck).
Data analysis
Target compound degradation during the 12-wk storage period
was modeled using the zero order, first order, second order, and
fractional conversion models [49]. Kinetic parameters were esti-
mated by application of the models with time as independent var-
iable for each experimental replicate, using the NLIN procedure of
SAS Version 9.4 (SAS Institute Inc.). Model evaluation and selec-
tion were based on the adjusted coefficient of determination
(R2adj).
Supporting Information
Supporting information can be found in the online version of this
article. Included are trans-epithelial electrical resistance data for
the ex vivo transport experiments; compositions of the saturated
salt solutions for moisture sorption analysis; physicochemical at-
tributes of the major compounds relevant to the Lipinski rule of
5 criteria, and a description of the quantification of D-pinitol con-
tent in the extract and fractions.
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